Oaktree Acquisition Corp. III Life Sciences (OACCU) Stock Price, News & Analysis

Company Overview

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCU) is a special purpose acquisition company formed to target businesses in the life sciences sector. As a blank‐check vehicle, the company raises capital through an initial public offering with the purpose of acquiring or merging with one or more operating companies. Its focus areas include biotechnology, pharmaceuticals, medical devices and healthcare services.

Established in Delaware and sponsored by affiliates of Oaktree Capital Management, OACCU leverages the resources and investment expertise of one of the world’s leading alternative asset managers. The company’s structure allows it to seek out emerging and established life science enterprises that can benefit from public market access and strategic guidance.

OACCU intends to complete its initial business combination within the timeframe prescribed by its governing charter, typically within two years of the IPO. During this period, the management team evaluates potential targets primarily in North America, though it retains the flexibility to consider opportunities globally. The company’s blank‐check format provides shareholders with the right to redeem their shares if they do not approve of a proposed transaction.

The leadership team at Oaktree Acquisition Corp. III Life Sciences comprises professionals drawn from Oaktree Capital Management and seasoned executives in the healthcare and life sciences industries. Their combined backgrounds in finance, research and corporate development are directed toward identifying high‐growth companies that can scale through strategic partnerships, operational improvements and access to public capital markets.

Key Stats

• Today's Range: $11.06 to $11.06
• 50-Day Range: $10.48 to $11.30
• 52-Week Range: $9.99 to $11.06
• Volume: 3,303 shs
• Average Volume: 4,655 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OACCU Stock Analysis - Frequently Asked Questions

How have OACCU shares performed this year?

Oaktree Acquisition Corp. III Life Sciences' stock was trading at $10.13 at the beginning of 2025. Since then, OACCU shares have increased by 6.6% and is now trading at $10.7940.

When did Oaktree Acquisition Corp. III Life Sciences IPO?

Oaktree Acquisition Corp. III Life Sciences (OACCU) raised $175 million in an initial public offering (IPO) on Thursday, October 24th 2024. The company issued 17,500,000 shares at a price of $10.00 per share. Jefferies, Citigroup and UBS Investment Bank acted as the underwriters for the IPO.

How do I buy shares of Oaktree Acquisition Corp. III Life Sciences?

Shares of OACCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Investment Offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:OACCU
• CIK: 2029769
• Web: N/A
• Phone: (213) 830-6300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A